Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together.
Read all the latest news and research about Mycobacterium avium subsp.paratuberculosis (MAP) and the treatment of Crohn’s and other diseases using AMAT and other therapies. Enjoy!
Healthy Living | Diet | Specific Carbohydrate Diet
The specific carbohydrate diet (SCD) is a strict grain-free, lactose-free and sucrose-free diet therapy.
Until recently the link between diet, gut bacteria and disease had been ignored by mainstream medicine. Only in the last decade, as the human microbiome took center stage in scientific research and attention to diet therapies began to grow, the SCD gained the attention of the medical community. Lately it has been investigated in multiple studies as a legitimate medical option for managing disease.
Healthy Living | Supplements | Oregano
People with digestive diseases, such as Crohn’s disease, ulcerative colitis, IBS and SIBO, may benefit from supplementation with Oil of Oregano due to it’s anti-microbial and anti-inflammatory properties. This article discusses the active ingredients of oregano, looks at research using oregano in digestive diseases and answers questions about the different forms and preparations of oregano.
The MAP Gap Newsletter | January 2018
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together.
Read all the latest news and research about Mycobacterium avium subsp. paratuberculosis (MAP) and the treatment of Crohn’s and other diseases using Anti-MAP and other therapies. Enjoy!
Krista – Crashing MAP’s party with RMAT
When I was diagnosed with Ulcerative colitis/Crohn’s disease six years ago, I was ignorant to the extent to which it would change my life. It altered all plans I had meticulously pieced together for a cohesive and creative existence within the world. The continual road of ups and downs not only affected me, they impacted my family, finances, and career. I knew people with UC/CD before I was diagnosed, yet had no idea of the daily struggles they faced, from immense pain and fatigue to brain fog to how your life stops when you have a flare. I lost my independence, financial nest egg, numerous jobs, relationships, and eventually myself.
Today is #GivingTuesday!
#GivingTuesday is finally here, and Human Para has a great way to maximize your donation dollars to fund MAP research and make a difference in the lives of Crohn’s patients and people with MAP-driven diseases around the world. If you’re new to the #GivingTuesday movement, you may want to read our introductory post first.
On November 28th, starting at 8:00 a.m. EST, Facebook and the Bill & Melinda Gates Foundation will match funds donated to 501(c)(3) charities up to $50,000 per nonprofit, until the $2 million in matching funds run out. Facebook is also waiving the fees for all donations made on #GivingTuesday to nonprofits through their site.
#GivingTuesday
We all know about Black Friday and Cyber Monday, but what is #GivingTuesday? In short – a great opportunity to fund some MAP research this holiday season!
Human Para’s #GivingTuesday campaign is hoping to raise $40,000 to fully fund our initial Joint Testing Study. All funds raised on #GivingTuesday will go directly to MAP research! If we raise the full amount needed for our initial study, we have more research projects waiting in the wings.
Joint MAP Testing Project
Human Paratuberculosis Foundation seeks to sponsor innovative research projects which will add to our understanding of MAP’s role in human disease. We encourage cooperative efforts among investigators, research centers, and other resources.
Human Para is pleased to announce our first research project in conjunction with 10 investigators from 5 different countries. This initial study seeks to confirm that Crohn’s disease patients have a significantly higher rate of MAP infection than individuals that do not have Crohn’s, and to compare more recent rapid culture methods from multiple laboratories. Our funding goal is $40,000 which will allow 210 samples (60 from Crohn’s patients, 150 controls) to be tested. MAP cultures and antibody studies will be performed in the laboratories of John Aitken, Timothy Bull, Irene Grant, Horacio Bach, Peilin Zhang and Raghava Potula.
To People with Crohn’s Disease
by Judith Eve Lipton, MD
originally published June 7, 2015, revised October 24, 2017
I receive many letters from people around the world asking about treating Crohn’s disease with antibiotics, under the theory that Crohn’s disease is an infection caused by MAP, Mycobacterium avium subspecies paratuberculosis. I am a psychiatrist, not a gastroenterologist (GI), and not qualified to make specific suggestions about treating Crohn’s disease. I never treat any GI patients myself, and never did. I will never tell people specific doses or protocols for treating MAP because every patient is different. If you elect to learn more and follow this path, you will need your own local physician. I am only offering general information.
The MAP Gap Newsletter | October 2017
Read all the latest news and research about Mycobacterium avium subsp. paratuberculosis (MAP) and the treatment of Crohn’s and other MAP-driven diseases.
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date MAP information to assist healthcare professionals and patients around the world to make informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together.